Monitoring Blood Pressure at Home

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
University of Alabama at Birmingham
Study ID
NCT06247111
Status
Active Not Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Remote Blood Pressure Monitoring + Telehealth — OTHER
    Remote blood pressure monitoring and pharmacist led telehealth intervention for blood pressure management
  • Usual care — OTHER
    Participants receive usual care, no intervention.

Study Details

The overall goal of this project is to determine if measuring blood pressure at home and staying in contact with a team of pharmacists and physicians to manage your blood pressure is feasible. The study will enroll 24 participants at UAB who are seen at the Emergency Department Post-Discharge Clinic. Half of the participants (12 patients) will be asked to measure their blood pressure at home, and half of the participants (12 patients) will continue to receive usual care. Participants who measure their blood pressure at home will also meet with a pharmacist weekly over the phone to discuss blood pressure readings and have blood pressure medications prescribed if needed. This program will last 3 months.

Key Dates

Start date
Jul 10, 2024
Status verified
Mar 2026
Primary completion
May 1, 2025
Completion
Dec 31, 2026

Study Design

Enrollment
24 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Placebo Comparator: Usual Care
    Participants receive usual care from providers to manage their blood pressure
  • Active Comparator: Remote Blood Pressure Monitoring + Telehealth
    Participants will undergo remote blood pressure monitoring and pharmacist led telehealth intervention for blood pressure management

Primary Outcome Measure

Total Number of Recruited Participants [ Time Frame: 2 years ]

Locations (1)

FacilityCityStateZIPSite coordinators
University of Alabama at BirminghamBirminghamAlabama35294-

Find similar trials in Birmingham, AL

Related Studies